FDA Approved: JADENU — Supplemental Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

FDA approved a supplemental application for Jadenu (deferasirox) from Novartis Pharmaceuticals Corporation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Overload Due to Blood Transfusions

Drugs mentioned

• JADENU (deferasirox)

Snippet

SUPPL AP for JADENU (DEFERASIROX)